{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:28:04Z","timestamp":1762896484455},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jviromet.2009.06.018","type":"journal-article","created":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T13:37:52Z","timestamp":1246023472000},"page":"205-215","source":"Crossref","is-referenced-by-count":12,"title":["Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library"],"prefix":"10.1016","volume":"161","author":[{"given":"Mehdi","family":"Houimel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koussay","family":"Dellagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2009.06.018_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4161\/hv.3.5.5060","article-title":"ELISA assays for rabies antibodies?","volume":"3","author":"Anders","year":"2007","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.jviromet.2009.06.018_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-1759(00)00221-0","article-title":"Methods for the generation of chicken monoclonal antibody fragments by phage display","volume":"242","author":"Andris-Widhopf","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2009.06.018_bib3","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib4","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.06.018_bib5","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1073\/pnas.88.18.7978","article-title":"Assembly of combinatorial antibody libraries on phage surfaces: the gene III site","volume":"88","author":"Barbas","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2009.06.018_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3233\/HAB-1993-4205","article-title":"Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture","volume":"4","author":"Bender","year":"1993","journal-title":"Hum. Antibodies Hybridomas"},{"key":"10.1016\/j.jviromet.2009.06.018_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.coph.2003.05.002","article-title":"New technologies in therapeutic antibody development","volume":"3","author":"Brekke","year":"2003","journal-title":"Curr. Opin . Pharmacol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd984","article-title":"Therapeutic antibodies for human diseases at the dawn of the twenty-first century","volume":"2","author":"Brekke","year":"2003","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.jviromet.2009.06.018_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2006.07.005","article-title":"Laboratory diagnosis of equine rabies and its implications for human postexposure prophylaxis","volume":"138","author":"Carrieri","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2009.06.018_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrmicro974","article-title":"Passive antibody therapy for infectious diseases","volume":"2","author":"Casadevall","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib11","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.141.8.2721","article-title":"Genetic restriction and fine specificity of human T cell clones reactive with rabies virus","volume":"141","author":"Celis","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib12","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0264-410X(02)00778-8","article-title":"A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries","volume":"21","author":"Cleaveland","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.06.018_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(95)80166-9","article-title":"The human immunoglobulin VH repertoire","volume":"16","author":"Cook","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jviromet.2009.06.018_bib14","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1093\/nar\/28.20.e85","article-title":"Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells","volume":"28","author":"Coronella","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jviromet.2009.06.018_bib15","first-page":"69","article-title":"The molecular basis for altered pathogenicity of lyssavirus variants","volume":"187","author":"Coulon","year":"1994","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jviromet.2009.06.018_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/eji.1830240409","article-title":"A directory of human germ-line V kappa segments reveals a strong bias in their usage","volume":"24","author":"Cox","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib18","first-page":"35","article-title":"Animal bites","volume":"30","author":"De Hoff","year":"1981","journal-title":"Md. State Med. J."},{"key":"10.1016\/j.jviromet.2009.06.018_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","article-title":"A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis","volume":"58","author":"de Kruif","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jviromet.2009.06.018_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1586\/14760584.2.3.399","article-title":"New approaches to the prevention and eradication of rabies","volume":"2","author":"Dietzschold","year":"2003","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jviromet.2009.06.018_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/3-540-27485-5_3","article-title":"Pathogenesis of rabies","volume":"292","author":"Dietzschold","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0092-1157(79)80038-4","article-title":"A collaborative study on the testing of rabies immune globulin (human) by the mouse neutralization test (MNT) and the rapid fluorescent focus inhibition test (RFFIT)","volume":"7","author":"Fitzgerald","year":"1979","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.jviromet.2009.06.018_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","article-title":"Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay","volume":"77","author":"Friguet","year":"1985","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2009.06.018_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","article-title":"Rabies virus glycoprotein is a trimer","volume":"187","author":"Gaudin","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2009.06.018_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0092-1157(87)90040-0","article-title":"Human rabies immunoglobulin assayed by the rapid fluorescent focus inhibition test suppresses active rabies immunization","volume":"15","author":"Gluck","year":"1987","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.jviromet.2009.06.018_bib26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin","volume":"193","author":"Goudsmit","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2009.06.018_bib27","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/j.1460-2075.1994.tb06626.x","article-title":"Isolation of high affinity human antibodies directly from large synthetic repertoires","volume":"13","author":"Griffiths","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.jviromet.2009.06.018_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/13550280590900409","article-title":"Pathophysiology of human paralytic rabies","volume":"11","author":"Hemachudha","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib29","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0002-9440(10)61107-8","article-title":"A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized","volume":"160","author":"Henderikx","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nbt1126","article-title":"Selecting and screening recombinant antibody libraries","volume":"23","author":"Hoogenboom","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1432-1327.1999.00430.x","article-title":"New inhibitors of Helicobacter Pylori urease holoenzyme selected from phage displayed peptide libraries","volume":"262","author":"Houimel","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jviromet.2009.06.018_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000030153","article-title":"Selection of human single chain Fv antibody fragments binding and inhibiting Helicobacter pylori urease","volume":"22","author":"Houimel","year":"2001","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib33","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4049\/jimmunol.150.4.1325","article-title":"Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation","volume":"150","author":"Ikematsu","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/13550280390193975","article-title":"Rabies virus infection: an update","volume":"9","author":"Jackson","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib35","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/eji.200526134","article-title":"The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries","volume":"35","author":"Kramer","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jmbi.1999.3444","article-title":"Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides","volume":"296","author":"Knappik","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib37","first-page":"99","article-title":"Comparative studies of two potency tests for antirabies serum: neutralization test in mice (MNT) and rapid fluorescent focus inhibition test (RFFIT)","volume":"64","author":"Kurz","year":"1986","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jviromet.2009.06.018_bib38","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2009.06.018_bib39","doi-asserted-by":"crossref","first-page":"37655","DOI":"10.1074\/jbc.M201374200","article-title":"Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor","volume":"277","author":"Langevin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2009.06.018_bib40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.copbio.2007.10.011","article-title":"Human monoclonal antibodies by immortalization of memory B cells","volume":"18","author":"Lanzavecchia","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0145-305X(02)00039-3","article-title":"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains","volume":"27","author":"Lefranc","year":"2003","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib42","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt1135","article-title":"Human antibodies from transgenic animals","volume":"23","author":"Lonberg","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0161-5890(86)90084-2","article-title":"Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain","volume":"23","author":"Macfarlan","year":"1986","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib44","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis","volume":"79","author":"Marissen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0022-2836(91)90498-U","article-title":"By-passing immunization. Human antibodies from V-gene libraries displayed on phage","volume":"222","author":"Marks","year":"1991","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0065-3527(08)00005-5","article-title":"Lyssaviruses: current trends","volume":"71","author":"Nadin-Davis","year":"2008","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jviromet.2009.06.018_bib47","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2009.06.018_bib48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/138920108786786358","article-title":"Monoclonal antibodies as innovative therapeutics","volume":"9","author":"Reichert","year":"2008","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib49","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nbt0905-1073","article-title":"Monoclonal antibody successes in the clinic","volume":"23","author":"Reichert","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib50","first-page":"95","article-title":"Can rabies be eradicated?","volume":"131","author":"Rupprecht","year":"2008","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.jviromet.2009.06.018_bib51","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice, Prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2009.06.018_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"Rupprecht","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jviromet.2009.06.018_bib53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0264-410X(98)00196-0","article-title":"Studies on the structures and antigenic properties of rabies virus glycoprotein analogues produced in yeast cells","volume":"17","author":"Sakamoto","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.06.018_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1380-2933(98)00022-0","article-title":"pFab-CMV, a single vector system for the rapid conversion of recombinant Fabs into whole IgG1 antibodies","volume":"4","author":"Sanna","year":"1999","journal-title":"Immunotechnology"},{"key":"10.1016\/j.jviromet.2009.06.018_bib55","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.4049\/jimmunol.147.5.1720","article-title":"Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions","volume":"147","author":"Sanz","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2009.06.018_bib56","first-page":"238","article-title":"Equine rabies immunoglobulin: a study on its clinical safety","volume":"103","author":"Satpathy","year":"2005","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.jviromet.2009.06.018_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-3542(00)00111-X","article-title":"Antibodies for the prevention and treatment of viral diseases","volume":"47","author":"Sawyer","year":"2000","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2009.06.018_bib58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000019115","article-title":"Protein displays of the human immunoglobulin heavy, kappa and lambda variable and joining regions","volume":"16","author":"Scaviner","year":"1999","journal-title":"Exp. Clin. Immunogenet."},{"key":"10.1016\/j.jviromet.2009.06.018_bib59","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1371\/journal.pmed.0040178","article-title":"Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza","volume":"4","author":"Simmons","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.jviromet.2009.06.018_bib60","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/4.11.2175","article-title":"Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I","volume":"4","author":"Tavormina","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jviromet.2009.06.018_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1749-6632.1995.tb55804.x","article-title":"A complete map of the human immunoglobulin VH locus","volume":"764","author":"Tomlinson","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jviromet.2009.06.018_bib62","first-page":"508","article-title":"Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene","volume":"24","author":"Wiktor","year":"1992","journal-title":"Biotechnology"},{"key":"10.1016\/j.jviromet.2009.06.018_bib63","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200504143521522","article-title":"Prophylaxis against rabies","volume":"352","author":"Wilde","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2009.06.018_bib64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/324628","article-title":"Postexposure treatment of rabies infection: can it be done without immunoglobulin? Clin","volume":"34","author":"Wilde","year":"2002","journal-title":"Infect. Dis."},{"key":"10.1016\/j.jviromet.2009.06.018_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prot.340160102","article-title":"Length distribution of CDRH3 in antibodies","volume":"16","author":"Wu","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/j.jviromet.2009.06.018_bib66","doi-asserted-by":"crossref","first-page":"S771","DOI":"10.1093\/clinids\/10.Supplement_4.S771","article-title":"The molecular biology of rabies viruses","volume":"10","author":"Wunner","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jviromet.2009.06.018_bib67","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1248\/bpb.29.1480","article-title":"Biotin-protein ratios and stability of biotinylated immunoglobulins as standards for the quantitation of biotin-binding immunoglobulins","volume":"29","author":"Yazawa","year":"2006","journal-title":"Biol. Pharm. Bull."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093409002997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093409002997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T21:58:29Z","timestamp":1710453509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093409002997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0166093409002997"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2009.06.018","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}